Suicide and Prescription Rates of Intranasal Corticosteroids and Nonsedating Antihistamines for Allergic Rhinitis: An Ecological Study

Journal of Clinical Psychiatry

Volumn 72, Issue 10, 2011, Pages 1423-1428

  Woo, Jong Min ^a,b,c   Gibbons, Robert D ^d   Qin, Ping ^e   Komarow, Hirsh ^f   Kim, Jong Bae ^d   Rogers, Christine A ^g   Mann, J John ^h   Postolache, Teodor T ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b Inje University College of Medicine   (South Korea)

^c Inje University   (South Korea)

^d UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^e AARHUS UNIVERSITY   (Denmark)

^f NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^g UNIVERSITY OF MASSACHUSETTS   (United States)

^h NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; CORTICOSTEROID; DECONGESTIVE AGENT;

ADOLESCENT; ADULT; AGED; ALLERGIC RHINITIS; ARTICLE; CHILD; DEATH CERTIFICATE; DEPRESSION; FEMALE; HUMAN; INFANT; INTERNATIONAL CLASSIFICATION OF DISEASES; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION SYSTEM; PRESCHOOL CHILD; PRESCRIPTION; PRIORITY JOURNAL; RISK REDUCTION; SCHOOL CHILD; SOCIAL STATUS; SUICIDAL BEHAVIOR; UNITED STATES; VITAL STATISTICS;

EID: 80054933509     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.10m06765     Document Type: Article

References (47)

1. Hawton K, van Heeringen K. Suicide. Lancet. 2009;373(9672):1372-1381. doi:10.1016/S0140-6736(09)60372-X PubMed
2. Levi F, La Vecchia C, Lucchini F, et al. Trends in mortality from suicide, 1965-99. Acta Psychiatr Scand. 2003;108(5):341-349. doi:10.1034/j.160-047.203.0147.x PubMed
3. Centers for Disease Control and Prevention. NCIPC: Web-based Injury Statistics Query and Reporting System (WISQARS). http://www.cdc.gov/ncipc/ wisqars/. Accessed November 10, 2005.
4. Tonelli LH, Stiller J, Rujescu D, et al. Elevated cytokine expression in the orbitofrontal cortex of victims of suicide. Acta Psychiatr Scand. 2008;117(3):198-206. doi:10.1/j.160-047.207.0128.x PubMed
5. Mann JJ, Huang YY, Underwood MD, et al. A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. Arch Gen Psychiatry. 2000;57(8):729-738. doi:10.101/archpsyc.57.8.729 PubMed
6. Qin P, Mortensen PB, Waltoft BL, et al. Allergy is associated with suicide completion with a possible mediating role of mood disorder: a population-based study. Allergy. 2011;66(5):658-664. doi:10.1/j.1398-95.2010. 02523.x PubMed
7. Timonen M, Viilo K, Hakko H, et al. Is seasonality of suicides stronger in victims with hospital-treated atopic disorders? Psychiatry Res. 2004;126(2):167-175. doi:10.1016/j.psychres.204.02.05 PubMed
8. Postolache TT, Stiller JW, Herrell R, et al. Tree pollen peaks are associated with increased nonviolent suicide in women. Mol Psychiatry. 2005;10(3):232-235. doi:10.1038/sj.mp.401620 PubMed
9. Timonen M, Jokelainen J, Hakko H, et al. Atopy and depression: results from the Northern Finland 1966 Birth Cohort Study. Mol Psychiatry. 2003;8(8):738-744. doi:10.1038/sj.mp.401274 PubMed
10. Tonelli LH, Katz M, Kovacsics CE, et al. Allergic rhinitis induces anxietylike behavior and altered social interaction in rodents. Brain Behav Immun. 2009;23(6):784-793. doi:10.1016/j.bi.209.02.017 PubMed
11. Tonelli LH, Hoshino A, Katz M, et al. Acute stress promotes aggressivelike behavior in rats made allergic to tree pollen. Int J Child Health Hum Dev. 2008;1(3):305-312. PubMed
12. Skoner DP. Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis. J Allergy Clin Immunol. 2001;108(suppl):S2-S8. doi:10.1067/mai.201.1569 PubMed
13. Gibbons RD, Hur K, Bhaumik DK, et al. The relationship between antidepressant medication use and rate of suicide. Arch Gen Psychiatry. 2005;62(2):165-172. doi:10.101/archpsyc.62.2.165 PubMed
14. Food and Drug Administration. Early Communication About an Ongoing Safety Review of Montelukast (Singulair). http://www.fda.gov/Drugs/DrugSafety/ PostmarketDrugSafetyInformationforPatientsandProviders/ DrugSafetyInformationforHeathcareProfessionals/ucm070618.htm. Accessed 2008. Accessibility verified July 26, 2011.
15. Wallace DV, Dykewicz MS, Bernstein DI, et al.; Joint Council of Allergy, Asthma and Immunology. The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol. 2008;122(suppl):S1-S84. doi:10.1016/j.jaci.208.06.03 PubMed
16. Okano M. Mechanisms and clinical implications of glucocorticosteroids in the treatment of allergic rhinitis. Clin Exp Immunol. 2009;158(2):164-173. doi:10.1/j.1365-249.209.04010.x PubMed
17. Tonelli LH, Postolache TT. Airborne inflammatory factors: "from the nose to the brain." Front Biosci (Schol Ed). 2010;2(1):135-152.
18. Sim TC, Reece LM, Hilsmeier KA, et al. Secretion of chemokines and other cytokines in allergen-induced nasal responses: inhibition by topical steroid treatment. Am J Respir Crit Care Med. 1995;152(3):927-933. PubMed
19. Warrington TP, Bostwick JM. Psychiatric adverse effects of corticosteroids. Mayo Clin Proc. 2006;81(10):1361-1367. doi:10.4065/81.10.1361 PubMed
20. Demoly P. Safety of intranasal corticosteroids in acute rhinosinusitis. Am J Otolaryngol. 2008;29(6):403-413. doi:10.1016/j.amjoto.207.1.04 PubMed
21. Derendorf H, Meltzer EO. Molecular and clinical pharmacology of intranasal corticosteroids: clinical and therapeutic implications. Allergy. 2008;63(10):1292-1300. doi:10.1/j.1398-95.208.01750.x PubMed
22. Allen DB. Systemic effects of intranasal steroids: an endocrinologist's perspective. J Allergy Clin Immunol. 2000;106(suppl):S179-S190. .1067/mai.20.1038 PubMed
23. Pokladnikova J, Meyboom RH, Vlcek J, et al. Intranasally administered corticosteroids and neuropsychiatric disturbances: a review of the international pharmacovigilance programme of the World Health Organization. Ann Allergy Asthma Immunol. 2008;101(1):67-73. doi:10.1016/S1081-1206(10)60837-X PubMed
24. Mansfield LE. Neuropsychiatric disorders during intranasal corticosteroid therapy. Ann Allergy Asthma Immunol. 2008;101(3):333-334. doi:10.1016/S1081- 1206(10)6050-5 PubMed
25. Simons FE. Advances in H1-antihistamines. N Engl J Med. 2004;351(21):2203-2217. doi:10.1056/NEJMra03121 PubMed
26. Lieberman P. Intranasal antihistamines for allergic rhinitis: mechanism of action. Allergy Asthma Proc. 2009;30(4):345-348. doi:10.250/ap.209.30.3263 PubMed
27. Bradding P, Feather IH, Wilson S, et al. Cytokine immunoreactivity in seasonal rhinitis: regulation by a topical corticosteroid. Am J Respir Crit Care Med. 1995;151(6):1900-1906. PubMed
28. Fokkens WJ, Godthelp T, Holm AF, et al. Local corticosteroid treatment: the effect on cells and cytokines in nasal allergic inflammation. Am J Rhinol. 1998;12(1):21-26. doi:10.250/10506589878210290 PubMed
29. Mann JJ. Neurobiology of suicidal behaviour. Nat Rev Neurosci. 2003;4(10):819-828. doi:10.1038/nrn120 PubMed
30. Oquendo MA, Placidi GP, Malone KM, et al. Positron emission tomography of regional brain metabolic responses to a serotonergic challenge and lethality of suicide attempts in major depression. Arch Gen Psychiatry. 2003;60(1):14-22. doi:10.101/archpsyc.60.1.14 PubMed
31. Tonelli LH, Holmes A, Postolache TT. Intranasal immune challenge induces sex-dependent depressive-like behavior and cytokine expression in the brain. Neuropsychopharmacology. 2008;33(5):1038-1048. doi:10.1038/sj.np.130148 PubMed
32. Galli SJ, Tsai M, Piliponsky AM. The development of allergic inflammation. Nature. 2008;454(7203):445-454. doi:10.1038/nature07204 PubMed
33. Pinar E, Eryigit O, Oncel S, et al. Efficacy of nasal corticosteroids alone or combined with antihistamines or montelukast in treatment of allergic rhinitis. Auris Nasus Larynx. 2008;35(1):61-66. doi:10.1016/j.anl.207.06.04 PubMed
34. Bielory L. Role of antihistamines in ocular allergy. Am J Med. 2002;113(suppl 9A):34S-37S. doi:10.1016/S02-9343(02)01435-3 PubMed
35. Craig TJ, Hanks CD, Fisher LH. How do topical nasal corticosteroids improve sleep and daytime somnolence in allergic rhinitis? J Allergy Clin Immunol. 2005;116(6):1264-1266. doi:10.1016/j.jaci.205.10.09 PubMed
36. Craig TJ, McCann JL, Gurevich F, et al. The correlation between allergic rhinitis and sleep disturbance. J Allergy Clin Immunol. 2004;114(suppl):S139- S145. doi:10.1016/j.jaci.204.08.04 PubMed
37. Fang BJ, Tonelli LH, Soriano JJ, et al. Disturbed sleep: linking allergic rhinitis, mood and suicidal behavior. Front Biosci (Schol Ed). 2010;2(1):30-46 [Schol Ed]. doi:10.2741/s4 PubMed
38. Wojnar M, Ilgen MA, Wojnar J, et al. Sleep problems and suicidality in the National Comorbidity Survey Replication. J Psychiatr Res. 2009;43(5):526-531. doi:10.1016/j.jpsychires.208.07.06 PubMed
39. Agargun MY, Beşiroǧlu L. Sleep and suicidality: do sleep disturbances predict suicide risk? Sleep. 2005;28(9):1039-1040. PubMed
40. Tashiro M, Mochizuki H, Iwabuchi K, et al. Roles of histamine in regulation of arousal and cognition: functional neuroimaging of histamine H1 receptors in human brain. Life Sci. 2002;72(4-5):409-414. doi:10.1016/S024- 3205(02)0276-2 PubMed
41. Messias E, Clarke DE, Goodwin RD. Seasonal allergies and suicidality: results from the National Comorbidity Survey Replication. Acta Psychiatr Scand. 2010;122(2):139-142. doi:10.1/j.160-047.209.01518.x PubMed
42. Wood KA. Nasal decongestant and psychiatric disturbance. Br J Psychiatry. 1994;164(4):566-567. doi:10.192/bjp.164.4.56b PubMed
43. Postolache TT, Komarow H, Tonelli LH. Allergy: a risk factor for suicide? Curr Treat Options Neurol. 2008;10(5):363-376. doi:10.107/s1940-08-039-4 PubMed
44. O'Donnell BF, Lawlor F, Simpson J, et al. The impact of chronic urticaria on the quality of life. Br J Dermatol. 1997;136(2):197-201. doi:10.1/j.1365-213.197.tb14895.x PubMed
45. Janelidze S, Mattei D, Westrin Å, et al. Cytokine levels in the blood may distinguish suicide attempters from depressed patients. Brain Behav Immun. 2011;25(2):335-339. doi:10.1016/j.bi.2010.10.010 PubMed
46. Lindqvist D, Janelidze S, Hagell P, et al. Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity. Biol Psychiatry. 2009;66(3):287-292. doi:10.1016/j.biopsych.209.01.030 PubMed
47. Steiner J, Bielau H, Brisch R, et al. Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide. J Psychiatr Res. 2008;42(2):151-157. doi:10.1016/j.jpsychires.206.10.013 PubMed